Literature DB >> 16484368

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Brett D Lindenbach1, Philip Meuleman, Alexander Ploss, Thomas Vanwolleghem, Andrew J Syder, Jane A McKeating, Robert E Lanford, Stephen M Feinstone, Marian E Major, Geert Leroux-Roels, Charles M Rice.   

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver disease, frequently progressing to cirrhosis and increased risk of hepatocellular carcinoma. Current therapies are inadequate and progress in the field has been hampered by the lack of efficient HCV culture systems. By using a recently described HCV genotype 2a infectious clone that replicates and produces infectious virus in cell culture (HCVcc), we report here that HCVcc strain FL-J6/JFH can establish long-term infections in chimpanzees and in mice containing human liver grafts. Importantly, virus recovered from these animals was highly infectious in cell culture, demonstrating efficient ex vivo culture of HCV. The improved infectivity of animal-derived HCV correlated with virions of a lower average buoyant density than HCVcc, suggesting that physical association with low-density factors influences viral infectivity. These results greatly extend the utility of the HCVcc genetic system to allow the complete in vitro and in vivo dissection of the HCV life cycle.

Entities:  

Mesh:

Year:  2006        PMID: 16484368      PMCID: PMC1533780          DOI: 10.1073/pnas.0511218103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.

Authors:  Marian E Major; Harel Dahari; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Avidan U Neumann; Stephen M Feinstone
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

2.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

3.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Akihiro Furusaka; Katsutoshi Tokushige; Masashi Mizokami; Takaji Wakita
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

5.  Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.

Authors:  Robert Thimme; Jens Bukh; Hans Christian Spangenberg; Stefan Wieland; Janell Pemberton; Carola Steiger; Sugantha Govindarajan; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

6.  Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.

Authors:  Svetlana Radaeva; Barbara Jaruga; Won-Ho Kim; Theo Heller; T Jake Liang; Bin Gao
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

7.  A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice.

Authors:  P Meuleman; P Vanlandschoot; G Leroux-Roels
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

8.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

9.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  181 in total

Review 1.  Animal models for studying hepatitis C and alcohol effects on liver.

Authors:  David F Mercer
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

Authors:  C Leboeuf; J Roser-Schilder; M Lambotin; S Durand; T Wu; C Fauvelle; B Su; E Bôle-Richard; M Deschamps; C Ferrand; P Tiberghien; P Pessaux; T F Baumert; E Robinet
Journal:  Gene Ther       Date:  2014-11-13       Impact factor: 5.250

3.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

4.  Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Authors:  Tomoko Date; Takanobu Kato; Junko Kato; Hitoshi Takahashi; Kenichi Morikawa; Daisuke Akazawa; Asako Murayama; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

6.  A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Authors:  Philip Meuleman; Maria Teresa Catanese; Lieven Verhoye; Isabelle Desombere; Ali Farhoudi; Christopher T Jones; Timothy Sheahan; Katarzyna Grzyb; Riccardo Cortese; Charles M Rice; Geert Leroux-Roels; Alfredo Nicosia
Journal:  Hepatology       Date:  2011-12-16       Impact factor: 17.425

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

Review 8.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

Review 10.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.